Market Overview:
The global in-vitro diagnostics enzymes market is expected to exhibit a CAGR of
8.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
In-vitro diagnostics are tests that are done on certain samples, including blood and tissue derived from the human body. They involve the use of assays and reagents to diagnose the medical condition in patients. They assist in providing necessary information pertaining to the diagnosis, screening, and monitoring of the ailment for the treatment and prevention of the same. Enzymes are widely employed in these diagnostic solutions for the detection of an extensive range of illnesses due to their excellent biocatalytic properties. Various enzymes, such as gelatinase-B, alanine transaminase, creatine kinase, acid phosphatase, aspartate transaminase and lactate dehydrogenase, are used as preferred biomarkers for the diagnosis of numerous ailments, including renal disease, cancer and rheumatoid arthritis.
The global market is primarily driven by the increasing demand for effective infectious disease diagnosis. This has led to the continual developments in the polymerase chain reaction (PCR) and its widespread applicability across the healthcare sector. PCR enables the easy detection of various organisms with improved precision and sensitivity, thereby providing an impetus to the market growth. Moreover, the development of enzyme biosensors has resulted in a considerable rise in enzyme utility for clinical diagnosis of certain medical conditions, such as tuberculosis, atypical pneumonia, streptococcal pharyngitis and ulcerative urogenital infections. This, in turn, is creating a positive outlook for the market. Apart from this, the rising number of cancer cases across the globe has led to the increasing demand for efficient diagnostic solutions that require the utilization of enzymes for histopathology of biopsy samples. Some of the other factors contributing to the market growth include continual improvements in the healthcare infrastructure and the rising investments in research and development (R&D) activities.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global in-vitro diagnostics enzymes market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on enzyme type, disease type, technology type and end use.
Breakup by Enzyme Type:
- Proteases
- Polymerase and Transcriptase
- Ribonuclease
- Others
Breakup by Disease Type:
- Infectious Disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune Diseases
- Others
Breakup by Technology Type:
- Histology Assays
- Molecular Diagnostics
- Clinical Chemistry
Breakup by End Use:
- Pharma and Biotech Companies
- Hospital and Diagnostic Labs
- Contract Research Organizations (CROs)
- Others
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Enzymes Technologies Ltd., Affymetrix (Thermo Fisher Scientific), Amano Enzyme Inc., American Laboratories Inc., Amicogen Inc., BBI Solutions, Biocatalysts Limited (Brain AG), Codexis Inc., Dyadic International Inc., F. Hoffmann-La Roche AG and Merck KGaA.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Enzyme Type, Disease Type, Technology Type, End Use, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Advanced Enzymes Technologies Ltd., Affymetrix (Thermo Fisher Scientific), Amano Enzyme Inc., American Laboratories Inc., Amicogen Inc., BBI Solutions, Biocatalysts Limited (Brain AG), Codexis Inc., Dyadic International Inc., F. Hoffmann-La Roche AG and Merck KGaA |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global in-vitro diagnostics enzymes market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global in-vitro diagnostics enzymes market?
- What are the key regional markets?
- What is the breakup of the market based on the enzyme type?
- What is the breakup of the market based on the disease type?
- What is the breakup of the market based on the technology type?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global in-vitro diagnostics enzymes market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global In-Vitro Diagnostics Enzymes Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Enzyme Type
6.1 Proteases
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Polymerase and Transcriptase
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Ribonuclease
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Disease Type
7.1 Infectious Disease
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Diabetes
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Oncology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cardiology
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Nephrology
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Autoimmune Diseases
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by Technology Type
8.1 Histology Assays
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Molecular Diagnostics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinical Chemistry
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by End Use
9.1 Pharma and Biotech Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital and Diagnostic Labs
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Contract Research Organizations (CROs)
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Advanced Enzymes Technologies Ltd.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Affymetrix (Thermo Fisher Scientific)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Amano Enzyme Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 American Laboratories Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Amicogen Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 BBI Solutions
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Biocatalysts Limited (Brain AG)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Codexis Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Dyadic International Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 F. Hoffmann-La Roche AG
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Merck KGaA
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: In-Vitro Diagnostics Enzymes Market: Major Drivers and Challenges
Figure 2: Global: In-Vitro Diagnostics Enzymes Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: In-Vitro Diagnostics Enzymes Market: Breakup by Enzyme Type (in %), 2021
Figure 5: Global: In-Vitro Diagnostics Enzymes Market: Breakup by Disease Type (in %), 2021
Figure 6: Global: In-Vitro Diagnostics Enzymes Market: Breakup by Technology Type (in %), 2021
Figure 7: Global: In-Vitro Diagnostics Enzymes Market: Breakup by End Use (in %), 2021
Figure 8: Global: In-Vitro Diagnostics Enzymes Market: Breakup by Region (in %), 2021
Figure 9: Global: In-Vitro Diagnostics Enzymes (Proteases) Market: Sales Value (in Million US$), 2016 and 2021
Figure 10: Global: In-Vitro Diagnostics Enzymes (Proteases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: In-Vitro Diagnostics Enzymes (Polymerase and Transcriptase) Market: Sales Value (in Million US$), 2016 and 2021
Figure 12: Global: In-Vitro Diagnostics Enzymes (Polymerase and Transcriptase) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: In-Vitro Diagnostics Enzymes (Ribonuclease) Market: Sales Value (in Million US$), 2016 and 2021
Figure 14: Global: In-Vitro Diagnostics Enzymes (Ribonuclease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: In-Vitro Diagnostics Enzymes (Other Enzyme Types) Market: Sales Value (in Million US$), 2016 and 2021
Figure 16: Global: In-Vitro Diagnostics Enzymes (Other Enzyme Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: In-Vitro Diagnostics Enzymes (Infectious Disease) Market: Sales Value (in Million US$), 2016 and 2021
Figure 18: Global: In-Vitro Diagnostics Enzymes (Infectious Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: In-Vitro Diagnostics Enzymes (Diabetes) Market: Sales Value (in Million US$), 2016 and 2021
Figure 20: Global: In-Vitro Diagnostics Enzymes (Diabetes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: In-Vitro Diagnostics Enzymes (Oncology) Market: Sales Value (in Million US$), 2016 and 2021
Figure 22: Global: In-Vitro Diagnostics Enzymes (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: In-Vitro Diagnostics Enzymes (Cardiology) Market: Sales Value (in Million US$), 2016 and 2021
Figure 24: Global: In-Vitro Diagnostics Enzymes (Cardiology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: In-Vitro Diagnostics Enzymes (Nephrology) Market: Sales Value (in Million US$), 2016 and 2021
Figure 26: Global: In-Vitro Diagnostics Enzymes (Nephrology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: In-Vitro Diagnostics Enzymes (Autoimmune Diseases) Market: Sales Value (in Million US$), 2016 and 2021
Figure 28: Global: In-Vitro Diagnostics Enzymes (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: In-Vitro Diagnostics Enzymes (Other Disease Types) Market: Sales Value (in Million US$), 2016 and 2021
Figure 30: Global: In-Vitro Diagnostics Enzymes (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: In-Vitro Diagnostics Enzymes (Histology Assays) Market: Sales Value (in Million US$), 2016 and 2021
Figure 32: Global: In-Vitro Diagnostics Enzymes (Histology Assays) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: In-Vitro Diagnostics Enzymes (Molecular Diagnostics) Market: Sales Value (in Million US$), 2016 and 2021
Figure 34: Global: In-Vitro Diagnostics Enzymes (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: In-Vitro Diagnostics Enzymes (Clinical Chemistry) Market: Sales Value (in Million US$), 2016 and 2021
Figure 36: Global: In-Vitro Diagnostics Enzymes (Clinical Chemistry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: In-Vitro Diagnostics Enzymes (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2016 and 2021
Figure 38: Global: In-Vitro Diagnostics Enzymes (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: In-Vitro Diagnostics Enzymes (Hospital and Diagnostic Labs) Market: Sales Value (in Million US$), 2016 and 2021
Figure 40: Global: In-Vitro Diagnostics Enzymes (Hospital and Diagnostic Labs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: In-Vitro Diagnostics Enzymes (Contract Research Organizations-CROs) Market: Sales Value (in Million US$), 2016 and 2021
Figure 42: Global: In-Vitro Diagnostics Enzymes (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: In-Vitro Diagnostics Enzymes (Other End Uses) Market: Sales Value (in Million US$), 2016 and 2021
Figure 44: Global: In-Vitro Diagnostics Enzymes (Other End Uses) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: North America: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 46: North America: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: United States: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 48: United States: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Canada: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 50: Canada: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Asia Pacific: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 52: Asia Pacific: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: China: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 54: China: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Japan: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 56: Japan: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: India: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 58: India: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: South Korea: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 60: South Korea: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Australia: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 62: Australia: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Indonesia: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 64: Indonesia: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Others: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 66: Others: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Europe: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 68: Europe: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Germany: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 70: Germany: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: France: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 72: France: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: United Kingdom: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 74: United Kingdom: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Italy: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 76: Italy: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Spain: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 78: Spain: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Russia: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 80: Russia: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Others: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 82: Others: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Latin America: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 84: Latin America: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Brazil: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 86: Brazil: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Mexico: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 88: Mexico: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Others: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 90: Others: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Middle East and Africa: In-Vitro Diagnostics Enzymes Market: Sales Value (in Million US$), 2016 and 2021
Figure 92: Middle East and Africa: In-Vitro Diagnostics Enzymes Market: Breakup by Country (in %), 2021
Figure 93: Middle East and Africa: In-Vitro Diagnostics Enzymes Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 94: Global: In-Vitro Diagnostics Enzymes Industry: SWOT Analysis
Figure 95: Global: In-Vitro Diagnostics Enzymes Industry: Value Chain Analysis
Figure 96: Global: In-Vitro Diagnostics Enzymes Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: In-Vitro Diagnostics Enzymes Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: In-Vitro Diagnostics Enzymes Market Forecast: Breakup by Enzyme Type (in Million US$), 2022-2027
Table 3: Global: In-Vitro Diagnostics Enzymes Market Forecast: Breakup by Disease Type (in Million US$), 2022-2027
Table 4: Global: In-Vitro Diagnostics Enzymes Market Forecast: Breakup by Technology Type (in Million US$), 2022-2027
Table 5: Global: In-Vitro Diagnostics Enzymes Market Forecast: Breakup by End Use (in Million US$), 2022-2027
Table 6: Global: In-Vitro Diagnostics Enzymes Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: In-Vitro Diagnostics Enzymes Market: Competitive Structure
Table 8: Global: In-Vitro Diagnostics Enzymes Market: Key Players